Medical/Pharmaceuticals
Agenda for the 4th Hong Kong Clinical-driven Robotics and Embodied AI Technology (CREATE) Symposium Officially Released
Leading Experts from Medicine, Research, Industry and Investment Revealed HONG KONG, Sept. 11, 2026 /PRNewswire/ -- Scheduled for September 22–23, 2026, the 4th Hong Kong Clinical-driven Robotics and Embodied AI Technology (CREATE) Symposium will be held at the Charles K. Kao Auditorium in Hong ...
2026-09-11 19:24
5702
THE GALIEN FOUNDATION ANNOUNCES INAUGURAL PRIX GALIEN JAPAN FORUM & AWARDS CEREMONY
Prestigious Life Sciences Platform and Awards Launch in Tokyo to Celebrate Breakthrough Innovation TOKYO, Sept. 11, 2026 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced that it will host the first Prix Galie...
2026-09-11 08:00
1645
Lancet Publication Marks Important Advance in Influenza Prevention for Older Adults
Phase 3 study demonstrates benefits of the first influenza vaccine to combine three proven approaches to enhancing protection for older adults in a single vaccine. MAIDENHEAD, United Kingdom, Sept. 11, 2026 /PRNewswire/ -- CSL Seqirus, a business of CSL (ASX: CSL; USOTC: CSLLY), today announced ...
2026-09-11 06:51
2526
Dr Hanan H. Balkhy Launches Candidacy for WHO Director-General, Pledges "A WHO the World Can Count On"
* Nominated by the Kingdom of Saudi Arabia * A physician trained in Saudi Arabia and the United States, with more than 30 years of experience spanning clinical medicine, academic research and international public health leadership * WHO Regional Director for the Eastern Mediterranean sets ou...
2026-09-10 20:55
1764
ZEISS announces commercial availability of bitoric hydrophobic monofocal IOL - the ZEISS AT LUCIA toric 721P
Launching at ESCRS in London, the world's first bitoric hydrophobic monofocal intraocular lens with a non-constant asphericity profile design expands the ZEISS LUCIA Family to treat cataracts while simultaneously correcting astigmatism. JENA, Germany, Sept. 10, 2026 /PRNewswire/ -- ZEISS Medical...
2026-09-10 20:00
1424
/C O R R E C T I O N -- CordenPharma/
In the news release, CordenPharma Boosts Aseptic Fill-Finish Capacity to 500 Million Sterile Injectable Units Per Year, issued 10-Sep-2026 by CordenPharma over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details ...
2026-09-10 19:28
1519
Novo Holdings invests in ForYou Medical to support global growth in advanced wound care manufacturing
SINGAPORE, Sept. 10, 2026 /PRNewswire/ -- Novo Holdings, a leading global healthcare and life sciences investor, today announced a strategic minority investment in Huizhou ForYou Medical Devices Co., Ltd. ("ForYou Medical"), a China-based contract development and manufacturing organisation (CDMO)...
2026-09-10 15:00
5748
BGI Genomics Launches "Digital Life Twin" Framework to Power Proactive Health
SHENZHEN, China, Sept. 9, 2026 /PRNewswire/ -- Commemorating BGI Group's 27th anniversary, BGI Genomics today introduced its Digital Life Twin framework alongside an advanced multi-omics diagnostic portfolio at the 2026 Global New Product Launch Event. Grounded in over two decades of population-s...
2026-09-09 21:45
2193
First Participant Dosed in First-in-Human Phase 1 Study of GZC8072, a Novel Ultra-Long-Acting Once-Weekly Oral Peptide GLP-1 RA
BEIJING and BRIDGEWATER, Mass., Sept. 9, 2026 /PRNewswire/ -- Gan&Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan&Lee) announced that the first participant has been dosed in a First-In-Human (FIH) Phase 1 study of GZC8072 tablets, a novel ultra-long-acting oral peptide GLP-1 RA form...
2026-09-09 21:00
3965
Clinical Psychologist Urges Women to Recognise the Signs of a Dysregulated Nervous System
MELBOURNE, Australia, Sept. 9, 2026 /PRNewswire/ -- Women are becoming
increasingly skilled at functioning while struggling, says Clinical
Psychologist Dr Jennifer Menon, who is urging women to recognise signs of
prolonged stress and trauma before reaching breaking point.
2026-09-09 20:56
1808
Moonwalk Biosciences Announces $70 Million Series B: NYSE Content Update
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Sept. 9, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begin...
2026-09-09 20:56
4562
Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer
Multicenter study to evaluate paxalisib plus gemcitabine for children and young
adults with recurrent or progressive AT/RT, where no approved therapies
currently exist
SYDNEY, Sept. 9, 2026 /PRNewswire/ -- Kazia Therapeutics Limited
2026-09-09 19:30
1631
Abbott and Sengkang General Hospital expand partnership to advance early detection of muscle loss and support healthy aging
* The expanded three-year collaboration will integrate muscle health screenings into hospital and community settings, train healthcare professionals, and increase public education * Since launching in 2023, the partnership has trained nearly 300 healthcare professionals to assess muscle healt...
2026-09-09 18:10
1612
Cleveland Clinic, RIKEN and IBM Team Advance to Finals for 2026 ACM Gordon Bell Prize
Joint research team modeled a 12,635-atom protein, the largest-known to be simulated using quantum computers. Breakthrough was achieved through quantum and classical methods working together, expanding quantum-centric supercomputing's potential in life sciences research. CLEVELAND and WAKO, Jap...
2026-09-09 12:00
1708
Metabolon Verus™ Metabolomics Profiling Kit Now Available to Order
A successful multi-site ring trial and early access program demonstrate the reproducibility, scalability, and biological insight of the Metabolon Verus™ Metabolomics Profiling Kit across laboratories worldwide MORRISVILLE, N.C., Sept. 8, 2026 /PRNewswire/ -- Metabolon, Inc., the global leader in...
2026-09-08 21:00
1304
Alebund Pharmaceuticals Announces FDA Clearance of IND Application for AP308 for the Treatment of IgA Nephropathy
SHANGHAI, Sept. 8, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced that it has recently received clearance from the U.S. Food and Drug Administration (FDA) of its Investigational ...
2026-09-08 20:15
1385
Kelun-Biotech's Partner Windward Bio Announces Positive Phase 2 Results of SKB378/WIN378 in Asthma, and Initiates Phase 3 Study
* The POLARIS-1 study enrolled 147 patients with uncontrolled, moderate-to-severe asthma, and the interim analysis was conducted on the first 98 patients. The analysis demonstrated a half-life of up to 75 days, with clinical effects consistent with twice-yearly dosing. * SKB378/WIN378 produce...
2026-09-08 20:02
1545
Ascletis Announces Initiation of Phase I Study in U.S. for Oral Amylin Receptor Peptide Agonist ASC36 for the Treatment of Obesity
- This trial marks the fourth Phase I peptide study for Ascletis this year. - ASC36 oral tablets achieved absolute oral bioavailability of 6% to 8% at steady state in non-human primate (NHP) studies utilizing Ascletis' proprietary Peptide Oral Transport ENhancement Technology (POTENT). - ASC36 o...
2026-09-08 18:10
1574
PeproMene Bio Announces Publication in The Lancet of Breakthrough Phase 1 Clinical Trial Results Demonstrating Deep and Durable Complete Responses in Relapsed/Refractory B-cell Lymphomas, including after prior CD19 CAR T-cell failure
IRVINE, Calif., Sept. 8, 2026 /PRNewswire/ -- PeproMene Bio, Inc. today
announced the publication inThe Lancet
2026-09-08 18:01
1642
/C O R R E C T I O N -- Wooree Group/
In the news release, Wooree Group Concludes Vitafoods Asia 2026, CEO Ji-yong Yoon Calls for Scientific Validation Standard for Liposome Claims, issued 07-Sep-2026 by Wooree Group over PR Newswire, we are advised by the company that the product name "Harutin" should read "Haroutine" throughout the...
2026-09-08 12:06
4265
Week's Top Stories
Most Reposted
Futurise Impact Report 2025 Highlights Progress in Regulatory Innovation Future-Ready Technologies
[Picked up by 272 media titles]
2026-09-09 13:26
Hyundai Motor Company Becomes Official Automotive Partner of the UEFA Champions League
[Picked up by 266 media titles]
2026-09-07 13:00
Novo Holdings invests in ForYou Medical to support global growth in advanced wound care manufacturing
[Picked up by 264 media titles]
2026-09-10 15:00People See One Brand. The Internet May Show Them Hundreds More.
[Picked up by 264 media titles]
2026-09-07 09:00Nuix Expands Generative AI for Legal Review, Debuts AI Chat for Case Data
[Picked up by 262 media titles]
2026-09-07 09:40Most Read
AIA Australia, Long Service Corporation, New Zealand Police and RMBL Investments Named 2026 Appian APJ Innovation Award Winners
2026-09-07 11:28
8352
Sungrow Calls for Scenario-based and integrated systems to Accelerate the Next Phase of the Renewable Energy Transition
2026-09-09 22:26
7065
Hyundai Motor Company Becomes Official Automotive Partner of the UEFA Champions League
2026-09-07 13:00
6488